KY

KY is a muscle-specific transglutaminase-like peptidase that localizes to the sarcomeric Z-band, where it forms a complex with filamin C (FLNC) and IGFN1 and proteolytically regulates FLNC stability and subcellular distribution (PMID:15385448, PMID:20206623). Loss of KY in mouse, zebrafish, and human muscle leads to mislocalization of FLNC and Xin, constitutive upregulation of titin-associated stress-signaling proteins (MLP, MARP2, Xin), impaired chaperone-assisted selective autophagy (CASA)-mediated FLNC turnover, defective hypertrophic response to mechanical load, and neuromuscular junction disorganization (PMID:11136708, PMID:16806927, PMID:29914939, PMID:15036332). Homozygous loss-of-function mutations in KY cause an early-onset human neuromuscular disorder with FLNC and Xin mislocalization in muscle fibers, confirming conservation of its sarcomeric regulatory function (PMID:27485408).

1. 2001 High

   Positional cloning of the ky locus revealed that KY encodes a novel muscle-restricted protein whose absence causes failed hypertrophic adaptation to mechanical demand and neuromuscular junction abnormalities, establishing KY as essential for skeletal muscle growth and NMJ integrity.

   Evidence Positional cloning, transcript analysis, histopathology and functional physiology of ky null mice

   PMID:11136708

   Open questions at the time

   • Molecular activity of KY protein unknown
   • Direct interacting partners not identified
   • Mechanism linking KY loss to NMJ disorganization unresolved
2. 2002 Medium

   Characterization of the C. elegans ortholog (ltd-1) showed that the LIM and transglutaminase-like domain architecture of KY is evolutionarily conserved, suggesting an ancient functional role for this domain combination.

   Evidence GFP reporter expression and domain analysis in C. elegans

   PMID:12204272

   Open questions at the time

   • Functional conservation beyond domain architecture not tested
   • No enzymatic activity demonstrated for LTD-1
   • Expression in hypodermal cells rather than muscle raises questions about tissue-specific roles across species
3. 2004 High

   Two studies resolved KY's molecular function and its NMJ role: KY was shown to possess transglutaminase-like protease activity that degrades filamin C, and ky null muscle displayed disorganized acetylcholine receptor clusters with UCP1 upregulation at NMJs, linking KY to both cytoskeletal proteolysis and synaptic signaling integrity.

   Evidence Co-immunoprecipitation, in vitro protease assays, cell-based degradation assays, immunofluorescence and microarray profiling of ky null mouse muscle

   PMID:15036332 PMID:15385448

   Open questions at the time

   • Catalytic mechanism and cleavage site on FLNC not defined
   • Whether KY protease activity is direct at the NMJ or acts indirectly through FLNC regulation unknown
   • MuSK pathway disruption not mechanistically dissected
4. 2006 Medium

   Analysis of ky null muscle showed constitutive upregulation of titin-associated stress-signaling proteins MLP, MARP2, and Xin as an early consequence of KY loss, linking KY to the titin-based mechanosensory pathway at the Z-band.

   Evidence Western blot and immunofluorescence of ky/ky mouse muscles across developmental time points

   PMID:16806927

   Open questions at the time

   • Whether KY directly modifies titin or titin-binding proteins not tested
   • Causal ordering between FLNC mislocalization and titin-signaling protein upregulation unclear
   • Single-lab observation without independent replication
5. 2010 High

   KY was localized to the sarcomeric Z-band and shown to form a ternary complex with IGFN1 and FLNC, defining the structural context in which KY exerts its proteolytic function.

   Evidence Immunofluorescence in C2C12 myotubes and neonatal cardiomyocytes, yeast two-hybrid screen, co-localization analysis

   PMID:20206623

   Open questions at the time

   • Stoichiometry and stability of the KY–IGFN1–FLNC complex not determined
   • Whether complex formation is required for protease activity unknown
   • No structural model of the complex available
6. 2016 Medium

   A homozygous frameshift mutation in KY was identified as the cause of an early-onset human neuromuscular disorder, with FLNC and Xin mislocalization in patient muscle fibers mirroring the mouse phenotype, confirming KY's conserved role in sarcomeric protein regulation.

   Evidence Whole-exome sequencing, muscle biopsy immunofluorescence for FLNC and Xin

   PMID:27485408

   Open questions at the time

   • Single family reported; additional kindreds needed to define clinical spectrum
   • Patient muscle not assessed for CASA pathway markers
   • Rescue experiment not performed
7. 2018 Medium

   KY was placed upstream of the chaperone-assisted selective autophagy (CASA) pathway: ky-deficient cells, zebrafish, and mouse muscle showed elevated BAG3 and other CASA factors, and ky-null zebrafish failed to mount a CASA response to mechanical challenge, revealing how KY couples mechanotransduction to protein quality control.

   Evidence CRISPR/Cas9 KO in C2C12 cells and zebrafish, RT-qPCR, protein analysis, viscous media swimming challenge

   PMID:29914939

   Open questions at the time

   • Direct mechanism by which KY regulates CASA factor expression or turnover not defined
   • Whether KY protease activity on FLNC is the upstream signal for CASA activation unknown
   • Single-lab observation across models but lacking biochemical reconstitution

• The catalytic mechanism and specific cleavage site(s) of KY on FLNC remain undefined, and it is unknown whether KY's protease activity is the direct signal that triggers CASA-mediated FLNC turnover or whether additional substrates exist.
• No crystal structure or cryo-EM model of KY
• Substrate specificity beyond FLNC not explored
• Mechanism linking KY protease activity to CASA pathway activation not biochemically reconstituted